CytomX Therapeutics, Inc. reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 651-675 of 794 matching filings.

Per page

25

Current page

27

8-K File 001-37587

8-K

Filing date: 10 Jan 2017
Reporting date: 10 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 29 Dec 2016
Reporting date: 28 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37587

8-K

Filing date: 14 Dec 2016
Reporting date: 14 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37587

8-K

Filing date: 13 Dec 2016
Reporting date: 13 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-214418

EFFECT filing

Filing date: 07 Dec 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 05 Dec 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37587

8-K

Filing date: 05 Dec 2016
Reporting date: 05 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Dec 2016
Reporting date: 30 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Dec 2016
Reporting date: 30 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Dec 2016
Reporting date: 29 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Dec 2016
Reporting date: 29 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 28 Nov 2016
Reporting date: 23 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Nov 2016
Reporting date: 23 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3/A File 333-214418

AMENDMENT NO. 1 TO FORM S-3

Filing date: 23 Nov 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 22 Nov 2016
Reporting date: 22 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 Nov 2016
Reporting date: 22 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Nov 2016
Reporting date: 17 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Nov 2016
Reporting date: 17 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 21 Nov 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Nov 2016
Reporting date: 15 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Nov 2016
Reporting date: 15 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Nov 2016
Reporting date: 10 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Nov 2016
Reporting date: 10 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 10 Nov 2016
Reporting date: 09 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Nov 2016
Reporting date: 09 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .